BlackRock LifePath ESG Index 2060 Fund Institutional
LEZIX
NASDAQ
| Weiss Ratings | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | BlackRock | |||
| Manager/Tenure (Years) | Christopher Chung (4), Peter Tsang (0) | |||
| Website | http://www.blackrock.com | |||
| Fund Information | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | BlackRock LifePath ESG Index 2060 Fund Institutional | |||
| Category | Target-Date 2060 | |||
| Sub-Category | Target Date | |||
| Prospectus Objective | Asset Allocation | |||
| Inception Date | Aug 18, 2020 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 2,000,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.86% | |||
| Dividend | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.25% | |||
| Asset Allocation | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.25% | |||
| Stock | 98.59% | |||
| U.S. Stock | 64.21% | |||
| Non-U.S. Stock | 34.38% | |||
| Bond | 1.04% | |||
| U.S. Bond | 0.96% | |||
| Non-U.S. Bond | 0.08% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.12% | |||
| Price History | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.96% | |||
| 30-Day Total Return | 1.56% | |||
| 60-Day Total Return | -0.13% | |||
| 90-Day Total Return | -1.79% | |||
| Year to Date Total Return | 1.06% | |||
| 1-Year Total Return | 10.90% | |||
| 2-Year Total Return | 32.59% | |||
| 3-Year Total Return | 31.76% | |||
| 5-Year Total Return | -- | |||
| Price | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $14.26 | |||
| 1-Month Low NAV | $12.37 | |||
| 1-Month High NAV | $14.26 | |||
| 52-Week Low NAV | $12.37 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $15.03 | |||
| 52-Week High Price (Date) | Dec 06, 2024 | |||
| Beta / Standard Deviation | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.94 | |||
| Standard Deviation | 16.14 | |||
| Balance Sheet | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 6.79M | |||
| Operating Ratios | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.25% | |||
| Turnover Ratio | 14.00% | |||
| Performance | LEZIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 15.85% | |||
| Last Bear Market Total Return | -15.59% | |||